McKesson updates its guidance framework, analyst consensus stays steady on the shares

McKesson fine-tunes its long-term guidance framework while Wall Street keeps a broadly steady view on the shares, with most houses rating the US healthcare distributor as a core defensive holding.

By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 09:08.

McKesson Corporation (US58155Q1031) sits in the S&P 500 as one of the largest US healthcare distributors by revenue. The Tuesday focus is on how analysts value the stock in light of its latest guidance framework for earnings and cash returns to shareholders.

How Wall Street values McKesson

Sell-side coverage on McKesson is concentrated among large US and European houses such as Goldman Sachs, JPMorgan and Morgan Stanley. Most of these firms keep a constructive stance on the stock, often with ratings in the Buy or Overweight range and price targets above the current share price.

Consensus data compiled by major financial platforms typically shows McKesson covered by around 20 research houses. A clear majority of these rate the shares positively, with a smaller group sitting at Hold and only isolated Sell recommendations, reflecting the company's position as a defensive healthcare distributor with strong cash flows.

Earnings power and cash returns

McKesson generates the bulk of its revenue by distributing pharmaceuticals and medical products across North America, with annual sales in recent years well above 200 billion US dollars. Earnings per share have grown over the past several years, helped by operational efficiency and consistent share repurchases.

The company has complemented its earnings trajectory with a share buyback program and a modest but regularly paid dividend. This combination of repurchases and dividends has supported total shareholder return, an important driver behind the positive stance of many analysts who cover the stock.

The business behind the stock

McKesson's core business is the distribution of branded, generic and specialty pharmaceuticals to pharmacies, hospitals and health systems in the US and Canada. It also supplies medical-surgical products and offers technology solutions that support pharmacy operations and healthcare providers.

Where the stock trades today

McKesson shares (US58155Q1031) trade on the New York Stock Exchange in US dollars. As of 2026-06-30, 09:08, the current share price and market capitalization are not precisely verifiable in this text, but the listing remains active on NYSE.

Key data on the McKesson shares

• Company: McKesson Corporation
• ISIN: US58155Q1031
• WKN: 953734
• Ticker: MCK
• Trading venue: NYSE
• Price (as of 2026-06-30, 09:08): not precisely verifiable in this text
• Market cap: large-cap US dollars (as of 2026)
• Sector / industry: Healthcare distribution / Health care providers & services
• Index membership: S&P 500
• Next earnings date: not officially scheduled

This article is for informational purposes only and does not constitute investment advice, a recommendation or an offer to buy or sell securities. All data were compiled with care but without guarantee.